Leigh Syndrome (Maternally Inherited, MILS)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Leigh Syndrome (Maternally Inherited, MILS) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT01694940

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disord…

United States1,000 participantsStarted 2011-01-31

RecruitingNot Applicable

NCT06967831

Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

In this project, the investigators are using iPSC lines derived from patients with Leigh syndrome that carry mutations in the mitochondrial (mtDNA) and in the n…

Germany80 participantsStarted 2020-03-01

Treatment: skin biopsy, generation of iPSCs

Leigh Syndrome (Maternally Inherited, MILS)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

All recent trials (2 shown)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

All recent trials (2 shown)